These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 17695275)

  • 1. [Notch-1 is involved in neurodegeneration in prion diseases].
    Ishikura N
    Nihon Rinsho; 2007 Aug; 65(8):1397-400. PubMed ID: 17695275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular pathogenesis in prion diseases.
    Crozet C; Beranger F; Lehmann S
    Vet Res; 2008; 39(4):44. PubMed ID: 18413130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch-1 activation and dendritic atrophy in prion disease.
    Ishikura N; Clever JL; Bouzamondo-Bernstein E; Samayoa E; Prusiner SB; Huang EJ; DeArmond SJ
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):886-91. PubMed ID: 15640354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of cerebral neurodegeneration in prion diseases.
    Tatzelt J; Schätzl HM
    FEBS J; 2007 Feb; 274(3):606-11. PubMed ID: 17288549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmissible and genetic prion diseases share a common pathway of neurodegeneration.
    Hegde RS; Tremblay P; Groth D; DeArmond SJ; Prusiner SB; Lingappa VR
    Nature; 1999 Dec; 402(6763):822-6. PubMed ID: 10617204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.
    Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R
    Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell culture models to unravel prion protein function and aberrancies in prion diseases.
    Bedecs K
    Methods Mol Biol; 2008; 459():1-20. PubMed ID: 18576144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Perineuronal Net in ME7 Prion Disease.
    Franklin SL; Love S; Greene JR; Betmouni S
    J Neuropathol Exp Neurol; 2008 Mar; 67(3):189-99. PubMed ID: 18344910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in tau phosphorylation associated with neurodegeneration in the ME7 model of prion disease.
    Asuni AA; Perry VH; O'Connor V
    Biochem Soc Trans; 2010 Apr; 38(2):545-51. PubMed ID: 20298219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion proteins: a biological role beyond prion diseases.
    Hu W; Rosenberg RN; Stüve O
    Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the natural variability of prion diseases.
    Geissen M; Krasemann S; Matschke J; Glatzel M
    Vaccine; 2007 Jul; 25(30):5631-6. PubMed ID: 17391814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A process of programmed cell death as a mechanisms of neuronal death in prion diseases].
    Chrétien F; Dorandeu A; Adle-Biassette H; Ereau T; Wingertsmann L; Brion F; Gray F
    Clin Exp Pathol; 1999; 47(3-4):181-91. PubMed ID: 10472738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
    Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
    Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microglia and prion disease.
    Brown DR
    Microsc Res Tech; 2001 Jul; 54(2):71-80. PubMed ID: 11455614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death.
    Cronier S; Laude H; Peyrin JM
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12271-6. PubMed ID: 15302929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of PrP in extraneural tissues.
    Brown KL; Ritchie DL; McBride PA; Bruce ME
    Microsc Res Tech; 2000 Jul; 50(1):40-5. PubMed ID: 10871547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglia and prion disease: a review.
    Brown DR; Kretzschmar HA
    Histol Histopathol; 1997 Jul; 12(3):883-92. PubMed ID: 9225170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follicular dendritic cell of the knock-in mouse provides a new bioassay for human prions.
    Kitamoto T; Mohri S; Ironside JW; Miyoshi I; Tanaka T; Kitamoto N; Itohara S; Kasai N; Katsuki M; Higuchi J; Muramoto T; Shin RW
    Biochem Biophys Res Commun; 2002 Jun; 294(2):280-6. PubMed ID: 12051707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
    White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
    Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prion diseases: what is the role of dendritic cells in the pathogenesis of transmissible prion diseases?].
    Bachy V; Aucouturier P
    Med Sci (Paris); 2010; 26(6-7):615-20. PubMed ID: 20619164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.